Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actions (Q35549761)

8 August 2017

1 reference

title

Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actions (English)

1 reference

8 August 2017

James P Tsikouris

1 reference

8 August 2017

Craig D Cox

series ordinal

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

1141-1152

1 reference

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Angiotensin II and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Coronary thrombosis: pathogenesis and clinical manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

The renin-angiotensin system and fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Regulation of Plasminogen Activator Production by Endothelial Cells: Role in Fibrinolysis and Local Proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Impaired fibrinolysis in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Molecular bases of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

The pathogenesis of atherosclerosis--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Tissue cooperation in a proteolytic cascade activating human interstitial collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Effects of blockade of the renin-angiotensin system on tissue factor and plasminogen activator inhibitor-1 synthesis in human cultured monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Angiotensin-converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Effect of enalapril and quinapril on forearm vascular ACE in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Angiotensin converting enzyme in the rat heart: studies of its inhibition in vitro and ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Impact of ramipril versus other angiotensin-converting enzyme inhibitors on outcome of unselected patients with ST-elevation acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Endothelial dysfunction: from physiology to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Endothelin ETA and ETB receptors mediate vascular smooth muscle contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Cloning and functional expression of a vascular smooth muscle endothelin 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Contribution of endogenous endothelin to the extension of myocardial infarct size in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Endothelin: systemic arterial and pulmonary effects of a new peptide with potent biologic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein beta (C/EBP beta) and Rel p50.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Coronary Plaque Disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Effect of losartan on plasma C-reactive protein in type 2 diabetic patients with microabluminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Blood pressure, stroke, and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Angiographic progression of coronary artery disease and the development of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

The underlying coronary lesion in myocardial infarction: Implications f coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Angiographic features of the coronary arteries during intracoronary thrombolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

The relationship between coronary artery lesions and myocardial infarcts: ulceration of atherosclerotic plaques precipitating coronary thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Effects of angiotensin-converting enzyme inhibition with perindopril on hemodynamics, arterial structure, and wall rheology in the hindquarters of atherosclerotic mini-pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Changes in ETA-, AT1- and AT2-Receptors in the Phenotypically Transformed Intimal Smooth Muscle Layer of Human Atherosclerotic Coronary Arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary Events

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.10.1141.32763

10.1592/PHCO.23.10.1141.32763

21 January 2018

Identifiers

DOI

1 reference

8 August 2017

1 reference